BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34245271)

  • 1. Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis.
    Ayenew W; Asmamaw G; Bitew T
    Int J Neuropsychopharmacol; 2021 Dec; 24(12):956-964. PubMed ID: 34245271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
    Sneider B; Pristed SG; Correll CU; Nielsen J
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1669-76. PubMed ID: 26256007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.
    Gallego JA; Bonetti J; Zhang J; Kane JM; Correll CU
    Schizophr Res; 2012 Jun; 138(1):18-28. PubMed ID: 22534420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
    Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
    Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
    Burness C; Corbet C; Beyene K; Webby C; Nankivell C; Cabasag P; Hari K; Fraser A; Gray S; Harrison J; Chan AHY
    Psychiatry Res; 2021 Aug; 302():113996. PubMed ID: 34126462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
    Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
    J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Chiu HF; Correll CU; Ungvari GS; Lai KY; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM
    Aust N Z J Psychiatry; 2015 Feb; 49(2):129-36. PubMed ID: 24923760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and correlates of antipsychotic polypharmacy in Hong Kong.
    Lung SLM; Lee HME; Chen YHE; Chan KWS; Chang WC; Hui LMC
    Asian J Psychiatr; 2018 Mar; 33():113-120. PubMed ID: 29574303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment.
    Toteja N; Gallego JA; Saito E; Gerhard T; Winterstein A; Olfson M; Correll CU
    Int J Neuropsychopharmacol; 2014 Jul; 17(7):1095-105. PubMed ID: 23673334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China.
    Hou CL; Ma XR; Zang Y; Jia FJ; Lin YQ; Chiu HF; Ungvari GS; Ng CH; Zhong BL; Cao XL; Li Y; Cai MY; Xiang YT
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):36-42. PubMed ID: 26521927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
    Wu YH; Lai CY; Chang YS
    Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital.
    Anozie IG; James BO; Omoaregba JO
    Niger Postgrad Med J; 2020; 27(1):30-36. PubMed ID: 32003359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice.
    Correll CU; Gallego JA
    Psychiatr Clin North Am; 2012 Sep; 35(3):661-81. PubMed ID: 22929872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.
    Matsui K; Tokumasu T; Takekita Y; Inada K; Kanazawa T; Kishimoto T; Takasu S; Tani H; Tarutani S; Hashimoto N; Yamada H; Yamanouchi Y; Takeuchi H
    Schizophr Res; 2019 Jul; 209():50-57. PubMed ID: 31182319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country.
    Armstrong KS; Temmingh H
    Braz J Psychiatry; 2017; 39(4):293-301. PubMed ID: 28177063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.
    Kadra G; Stewart R; Shetty H; Jackson RG; Greenwood MA; Roberts A; Chang CK; MacCabe JH; Hayes RD
    BMC Psychiatry; 2015 Jul; 15():166. PubMed ID: 26198696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study.
    Zhang SZ; Mu YG; Liu Q; Shi Y; Guo LH; Li LZ; Yang FD; Wang Y; Li T; Mei QY; He HB; Chen ZY; Su ZH; Liu TB; Xie SP; Tan QR; Zhang JB; Zhang CP; Sang H; Mi WF; Zhang HY
    BMC Psychiatry; 2019 Jul; 19(1):216. PubMed ID: 31291931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
    Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
    Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.
    Kishimoto T; Watanabe K; Uchida H; Mimura M; Kane JM; Correll CU
    Psychiatry Res; 2013 Oct; 209(3):406-11. PubMed ID: 23602697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.